nitazoxanide has been researched along with 2019 Novel Coronavirus Disease in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 33 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agard, DA; Ashworth, A; Barrio-Hernandez, I; Batra, J; Beltrao, P; Bennett, MJ; Bohn, M; Bouhaddou, M; Braberg, H; Broadhurst, DJ; Cai, Y; Cakir, M; Calviello, L; Cavero, DA; Chang, JCJ; Chorba, JS; Craik, CS; d'Enfert, C; Dai, SA; Eckhardt, M; Emerman, M; Fabius, JM; Fletcher, SJ; Floor, SN; Foussard, H; Frankel, AD; Fraser, JS; Fujimori, DG; Ganesan, SJ; García-Sastre, A; Gordon, DE; Gross, JD; Guo, JZ; Haas, K; Haas, P; Hernandez-Armenta, C; Hiatt, J; Huang, XP; Hubert, M; Hüttenhain, R; Ideker, T; Jacobson, M; Jang, GM; Jura, N; Kaake, RM; Kim, M; Kirby, IT; Klippsten, S; Koh, C; Kortemme, T; Krogan, NJ; Kuzuoglu-Ozturk, D; Li, Q; Liboy-Lugo, J; Lin, Y; Liu, X; Liu, Y; Lou, K; Lyu, J; Mac Kain, A; Malik, HS; Mathy, CJP; McGregor, MJ; Melnyk, JE; Memon, D; Meyer, B; Miorin, L; Modak, M; Moreno, E; Mukherjee, S; Naing, ZZC; Noack, J; O'Meara, MJ; O'Neal, MC; Obernier, K; Ott, M; Peng, S; Perica, T; Pilla, KB; Polacco, BJ; Rakesh, R; Rathore, U; Rezelj, VV; Richards, AL; Roesch, F; Rosenberg, OS; Rosenthal, SB; Roth, BL; Roth, TL; Ruggero, D; Safari, M; Sali, A; Saltzberg, DJ; Savar, NS; Schwartz, O; Sharp, PP; Shen, W; Shengjuler, D; Shi, Y; Shoichet, BK; Shokat, KM; Soucheray, M; Stroud, RM; Subramanian, A; Swaney, DL; Taunton, J; Tran, QD; Trenker, R; Tummino, TA; Tutuncuoglu, B; Ugur, FS; Vallet, T; Venkataramanan, S; Verba, KA; Verdin, E; Vignuzzi, M; von Zastrow, M; Wang, HY; Wankowicz, SA; Wenzell, NA; White, KM; Xu, J; Young, JM; Zhang, Z; Zhou, Y | 1 |
| Chen, J; Chen, W; Choudhry, N; Xu, D; Yang, Z; Zanin, M; Zhao, X | 1 |
| Assis, LC; da Cunha, EFF; de Almeida La Porta, F; de Castro Ramalho, T; de Castro, AA; de Jesus, JPA; Kuca, K; Nepovimova, E | 1 |
| Tsanni, A | 1 |
| Concepción Carrillo, LE; Iturbe Esquivel, B; Mendieta Zeron, H; Meneses Calderón, J | 1 |
| Akpomiemie, G; Bosch, B; Casas, CP; Ellis, L; Hill, A; Johnstone, H; Owen, A; Simmons, B; Sokhela, S; Venter, WDF; Woods, J | 1 |
| Abla, N; Arbe-Barnes, S; Chandiwana, N; Chughlay, MF; Dineka, Y; Duparc, S; Francois Venter, WD; Hill, A; Johnstone, H; Ju, C; Kim, B; Kruger, C; Marrast, AC; Miller, R; Owen, A; Windgassen, D | 1 |
| Bolinger, AA; Chen, H; Li, H; Li, J; Xu, J; Xue, Y; Zhou, J; Zhou, M | 1 |
| Muñoz-Cordero, B; Romero-Cabello, R; Romero-Feregrino, R; Sevilla-Fuentes, S | 1 |
| Altieri, M; Bisecco, A; Boffa, L; Capuano, R; Cavalla, P; Cocco, E; Cordioli, C; De Luca, G; Di Gregorio, M; Fantozzi, R; Gajofatto, A; Gallo, A; Gasperini, C; Guaschino, C; Lorefice, L; Nociti, V; Paolicelli, D; Pinardi, F; Prosperini, L; Radaelli, M; Ragonese, P; Solaro, C; Torri Clerici, V; Tortorella, C | 1 |
| Kelleni, MT | 3 |
| Arshad, U; Biagini, GA; Box, H; Curley, P; Neary, M; Owen, A; Pertinez, H; Rajoli, RKR; Rannard, SP; Sharp, J; Tatham, L; Valentijn, A | 1 |
| Barlow, A; Barlow, B; Claassen, CW; Heavner, JJ; Heavner, MS; Landolf, KM; Yeung, SYA | 1 |
| Şimşek Yavuz, S; Ünal, S | 1 |
| Anastasiou, IA; Eleftheriadou, I; Tentolouris, A; Tentolouris, N; Tsilingiris, D | 1 |
| Hemmati, F; Hemmati-Dinarvand, M; Saedi, S; Seghatoleslam, A; Zarei, M | 1 |
| Calderón, JM; Padmanabhan, S; Zerón, HM | 1 |
| Alonso, DF; Farina, HG | 1 |
| Briones Garduño, JC; De la Cruz Ávila, L; Díaz Meza, S; Figueroa Flores, MDR; Mendieta Zerón, H; Meneses Calderón, J; Meneses Figueroa, J; Padmanabhan, S; Paniagua Coria, L; Ramírez Chacón, R; Vargas Contretas, MJ | 1 |
| Aljayyoussi, G; Arshad, U; Biagini, GA; Boffito, M; Box, H; Bray, PG; Curley, P; David, C; Hill, A; Hong, WD; Khoo, SH; Liptrott, NJ; Neary, M; O'Neill, PM; Owen, A; Pennington, SH; Pertinez, H; Rajoli, RKR; Rannard, SP; Sharp, J; Tatham, L; Valentijn, A; Ward, SA | 1 |
| Chérrez-Ojeda, I; Felix, M; Vanegas, E | 1 |
| Devarajan, PV; Lokhande, AS | 1 |
| Kumar, D; Trivedi, N; Verma, A | 1 |
| Alves, PA; Carbonieri, MN; Cordeiro, AT; Cruz, FF; de Carvalho, AF; de Moraes, NF; De Oliveira, LFG; Dos Santos, EA; Dos Santos, IS; Fernandes, APSM; Franchini, KG; Gonçalves, JMJ; Junior, WF; Lapa E Silva, JR; Lima, CC; Luiz, RR; Maciel, PVM; Magri, E; Marques, RE; Melo-Junior, MAC; Moura, MA; Paes, NF; Pelosi, P; Proença-Módena, JL; Rocco, PRM; Rocha, RP; Silva, PL; Tierno, PFGMM; Trivella, DBB | 1 |
| Adeagbo, BA; Adebiyi, AO; Adefuye, BO; Akinloye, A; Bolaji, OO; Fagbamigbe, AF; Fowotade, A; Happi, C; Ladipo, OT; Ojo, TO; Olagunju, A; Olagunju, OI; Olagunoye, A; Onayade, A; Owen, A; Rannard, S | 1 |
| Wen, S; Xu, X; Yadav, AK; Yu, L | 1 |
| Cicka, D; Sukhatme, VP | 1 |
| Barreto-Alves, JA; Fakhouri, R; Martins-Filho, PR | 1 |
| Koch, M | 1 |
| Cowling, VH; Fordyce, EAF; Gray, DW; Green, CJ; Pearson, LA; Petit, AP | 1 |
| Byrne, P; Harrington, P; O Murchu, E; O'Neill, M; Ryan, M; Spillane, S | 1 |
9 review(s) available for nitazoxanide and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Topics: Antiviral Agents; China; Coronavirus Protease Inhibitors; COVID-19; COVID-19 Drug Treatment; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; SARS-CoV-2; Small Molecule Libraries | 2020 |
Therapeutic potential of salicylamide derivatives for combating viral infections.
Topics: Antiviral Agents; COVID-19; Humans; Nitro Compounds; Salicylamides; Thiazoles; Virus Replication | 2023 |
Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azetidines; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Immunomodulation; Interferon-alpha; Lopinavir; Nelfinavir; Nitro Compounds; Pandemics; Pneumonia, Viral; Purines; Pyrazoles; Ribavirin; Ritonavir; SARS-CoV-2; Sulfonamides; Thiazoles | 2020 |
Antiviral treatment of COVID-19
Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Nitro Compounds; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2; Thiazoles | 2020 |
Mysterious Virus: A Review on Behavior and Treatment Approaches of the Novel Coronavirus, 2019-nCoV.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Disease Outbreaks; Humans; Nitro Compounds; Pandemics; Pneumonia, Viral; SARS-CoV-2; Thiazoles | 2020 |
A review on possible mechanistic insights of Nitazoxanide for repurposing in COVID-19.
Topics: Antiprotozoal Agents; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Humans; Immunity, Innate; Nitro Compounds; SARS-CoV-2; Thiazoles | 2021 |
Possible treatment and strategies for COVID-19: review and assessment.
Topics: Adenosine Monophosphate; Alanine; Amides; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Antiparasitic Agents; Antiviral Agents; Cannabinoids; Chloroquine; Complement Inactivating Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; COVID-19 Vaccines; Dexamethasone; Drug Combinations; Enzyme Inhibitors; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Ivermectin; Lopinavir; Nitro Compounds; Pyrazines; Ritonavir; SARS-CoV-2; Teicoplanin; Tetracyclines; Thiazoles | 2020 |
Antiviral treatment in COVID-19: which is the most promising?-a narrative review.
Topics: Adenosine Monophosphate; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azetidines; Chloroquine; COVID-19; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Ivermectin; Lopinavir; Nitro Compounds; Oseltamivir; Purines; Pyrazines; Pyrazoles; Ribavirin; Ritonavir; Sulfonamides; Thiazoles | 2021 |
Interventions in an Ambulatory Setting to Prevent Progression to Severe Disease in Patients With COVID-19: A Systematic Review.
Topics: Ambulatory Care; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Antiviral Agents; COVID-19; Disease Progression; Humans; Interferons; Ivermectin; Nitro Compounds; Polyethylene Glycols; Thiazoles | 2022 |
6 trial(s) available for nitazoxanide and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infection.
Topics: Antiviral Agents; Carbamates; COVID-19; Humans; Imidazoles; Nitro Compounds; Pyrrolidines; SARS-CoV-2; Sofosbuvir; South Africa; Thiazoles; Treatment Outcome; Valine | 2022 |
Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trial.
Topics: Adult; COVID-19; Humans; Outpatients; SARS-CoV-2; Thiazoles; Treatment Outcome | 2022 |
Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; Hydroxychloroquine; Nitro Compounds; Pandemics; Pneumonia, Viral; Prognosis; Randomized Controlled Trials as Topic; Respiration, Artificial; Risk Factors; SARS-CoV-2; Single-Blind Method; Thiazoles | 2020 |
Nitazoxanide against COVID-19 in three explorative scenarios.
Topics: Adult; Ambulatory Care; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Follow-Up Studies; Hospitalization; Humans; Male; Mexico; Nitro Compounds; Pandemics; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; SARS-CoV-2; Thiazoles; Treatment Outcome | 2020 |
Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trial.
Topics: Adult; COVID-19; Humans; Nitro Compounds; SARS-CoV-2; Thiazoles; Treatment Outcome | 2021 |
Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antiviral Agents; Atazanavir Sulfate; Clinical Trials, Phase II as Topic; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; Drug Administration Schedule; Drug Combinations; Drug Repositioning; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Nigeria; Nitro Compounds; Pilot Projects; Randomized Controlled Trials as Topic; Ritonavir; RNA, Viral; SARS-CoV-2; Severity of Illness Index; Standard of Care; Thiazoles; Treatment Outcome; Viral Load; Young Adult | 2021 |
18 other study(ies) available for nitazoxanide and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
Topics: Animals; Antiviral Agents; Betacoronavirus; Chlorocebus aethiops; Cloning, Molecular; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Evaluation, Preclinical; Drug Repositioning; HEK293 Cells; Host-Pathogen Interactions; Humans; Immunity, Innate; Mass Spectrometry; Molecular Targeted Therapy; Pandemics; Pneumonia, Viral; Protein Binding; Protein Biosynthesis; Protein Domains; Protein Interaction Mapping; Protein Interaction Maps; Receptors, sigma; SARS-CoV-2; SKP Cullin F-Box Protein Ligases; Vero Cells; Viral Proteins | 2020 |
Effect of drug metabolism in the treatment of SARS-CoV-2 from an entirely computational perspective.
Topics: Adenine; Adenosine; Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; Drug Design; Drug Discovery; Humans; Metabolic Networks and Pathways; Molecular Docking Simulation; Nitro Compounds; Pyrazines; Pyrrolidines; Ribavirin; SARS-CoV-2; Thiazoles | 2021 |
African scientists race to test COVID drugs - but face major hurdles.
Topics: Africa; Amides; Amodiaquine; Artesunate; Atazanavir Sulfate; Carbamates; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Cytidine; Drug Approval; Drug Evaluation, Preclinical; Drug Repositioning; Drug Therapy, Combination; Humans; Hydroxylamines; Imidazoles; Ivermectin; Naphthyridines; Nitro Compounds; Pregnenediones; Pyrazines; Pyrrolidines; Ritonavir; Sample Size; Thiazoles; Valine; World Health Organization | 2021 |
Rural treatment of COVID-19 patients with pirfenidone, nitazoxanide and colchicine. Case series.
Topics: Adult; Colchicine; COVID-19; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; SARS-CoV-2 | 2022 |
Outpatient treatment of COVID-19: an experience with 552 cases in Mexico.
Topics: Azithromycin; COVID-19; Humans; Mexico; Outpatients; Prednisone; SARS-CoV-2; Treatment Outcome | 2023 |
Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs.
Topics: COVID-19; COVID-19 Vaccines; Fingolimod Hydrochloride; Humans; mRNA Vaccines; Multiple Sclerosis; Natalizumab; RNA, Messenger; SARS-CoV-2 | 2023 |
The African Kelleni's roadmap using nitazoxanide and broad-spectrum antimicrobials to abort returning to COVID-19 square one.
Topics: Anti-Infective Agents; COVID-19; Humans; Nitro Compounds; SARS-CoV-2; Thiazoles | 2023 |
Quantitation of tizoxanide in multiple matrices to support cell culture, animal and human research.
Topics: Animals; Cell Culture Techniques; Chromatography, Liquid; COVID-19; Humans; Mice; SARS-CoV-2; Tandem Mass Spectrometry | 2023 |
Nitazoxanide/azithromycin combination for COVID-19: A suggested new protocol for early management.
Topics: Antiparasitic Agents; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Humans; Nitro Compounds; Pandemics; Pneumonia, Viral; SARS-CoV-2; Thiazoles | 2020 |
In Vitro Data of Current Therapies for SARS-CoV-2.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; China; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Emetine; Homoharringtonine; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Nitro Compounds; Pandemics; Pneumonia, Viral; SARS-CoV-2; Teicoplanin; Thiazoles | 2020 |
Repurposing of host-based therapeutic agents for the treatment of coronavirus disease 2019 (COVID-19): a link between antiviral and anticancer mechanisms?
Topics: Anticholesteremic Agents; Antineoplastic Agents; Antiparasitic Agents; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Administration Schedule; Drug Repositioning; Host-Pathogen Interactions; Humans; Hypoglycemic Agents; Ivermectin; Lovastatin; Metformin; Nitro Compounds; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severity of Illness Index; Thiazoles | 2020 |
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis.
Topics: Adult; Antiviral Agents; Computer Simulation; COVID-19; COVID-19 Drug Treatment; Drug Dosage Calculations; Drug Repositioning; Female; Humans; Lung; Male; Middle Aged; Models, Biological; Nitro Compounds; Reproducibility of Results; Thiazoles; Tissue Distribution; Young Adult | 2021 |
The unusual experience of managing a severe COVID-19 case at home: what can we do and where do we go?
Topics: Adrenal Cortex Hormones; Ambulatory Care; Antiparasitic Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Enoxaparin; Female; Humans; Middle Aged; Nitro Compounds; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; SARS-CoV-2; Severity of Illness Index; Telemedicine; Thiazoles; Thorax; Tomography, X-Ray Computed | 2020 |
Available drugs and supplements for rapid deployment for treatment of COVID-19.
Topics: Adenosine Monophosphate; Alanine; Animals; COVID-19; COVID-19 Drug Treatment; Disease Models, Animal; Drug Repositioning; Flavonoids; Humans; Mice; Nitro Compounds; Pharmaceutical Preparations; SARS-CoV-2; Small Molecule Libraries; Teicoplanin; Thiazoles | 2021 |
Potential role for nitazoxanide in treating SARS-CoV-2 infection.
Topics: Antiviral Agents; COVID-19; Humans; Nitro Compounds; SARS-CoV-2; Thiazoles | 2020 |
[2020: Evidence-Based Medicine odyssey. The fall and rise of evidence-based medicine in the year of coronavirus.]
Topics: Access to Information; Antiviral Agents; Brazil; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Disclosure; Evidence-Based Medicine; Humans; Hydroxychloroquine; Italy; Nitro Compounds; Pandemics; Politics; Propaganda; SARS-CoV-2; Thiazoles; United States | 2021 |
Development of a High-Throughput Screening Assay to Identify Inhibitors of the SARS-CoV-2 Guanine-N7-Methyltransferase Using RapidFire Mass Spectrometry.
Topics: Antiparasitic Agents; Antiviral Agents; Cloning, Molecular; COVID-19; Drug Repositioning; Enzyme Assays; Enzyme Inhibitors; Escherichia coli; Exoribonucleases; Gene Expression; Genetic Vectors; High-Throughput Screening Assays; Humans; Kinetics; Mass Spectrometry; Methylation; Nitro Compounds; Prescription Drugs; Recombinant Fusion Proteins; RNA Caps; RNA, Viral; SARS-CoV-2; Small Molecule Libraries; Thiazoles; Viral Nonstructural Proteins; Virus Replication | 2021 |
NSAIDs/nitazoxanide/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azithromycin; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Drug Repositioning; Humans; Interferons; Interleukin-6; Nitro Compounds; Observational Studies as Topic; SARS-CoV-2; Thiazoles | 2022 |